Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime by Wood, Evan et al.
BioMed  Central
Page 1 of 4
(page number not for citation purposes)
Substance Abuse Treatment, 
Prevention, and Policy
Open Access Short Report
Impact of a medically supervised safer injecting facility on drug 
dealing and other drug-related crime
Evan Wood*1,2, Mark W Tyndall1,2, Calvin Lai1, Julio SG Montaner1,2 and 
Thomas Kerr1,2
Address: 1British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608 - 1081 Burrard Street, Vancouver BC V6Z 1Y6, Canada and 
2Department of Medicine, University of British Columbia, 3300 - 950 West 10th Avene, Vancouver BC V5Z 4E3, Canada
Email: Evan Wood* - ewood@cfenet.ubc.ca; Mark W Tyndall - mtyndall@cfenet.ubc.ca; Calvin Lai - calvin@cfenet.ubc.ca; 
Julio SG Montaner - jmontaner@cfenet.ubc.ca; Thomas Kerr - tkerr@cfenet.ubc.ca
* Corresponding author    
Abstract
North America's first medically supervised safer injecting facility (SIF) recently opened in
Vancouver, Canada. One of the concerns prior to the SIF's opening was that the facility might lead
to a migration of drug activity and an increase in drug-related crime. Therefore, we examined crime
rates in the neighborhood where the SIF is located in the year before versus the year after the SIF
opened. No increases were seen with respect to drug trafficking (124 vs. 116) or assaults/robbery
(174 vs. 180), although a decline in vehicle break-ins/vehicle theft was observed (302 vs. 227). The
SIF was not associated with increased drug trafficking or crimes commonly linked to drug use.
Introduction
Despite existing interventions [1,2], illicit injection drug
use continues to fuel infectious disease and fatal overdose
epidemics in many settings, and has prompted substantial
community concern [3-5]. Public health programming
aimed at reducing the harms of illicit drug use commonly
face community and legal opposition due to concerns that
these services may lead to increases in criminal activity in
their vicinity [6].
In an effort to address longstanding epidemics of HIV and
drug-related overdose, Vancouver opened North Amer-
ica's first medically supervised safer injection facility (SIF)
on September 22, 2003. Consistent with most SIF [7],
within the facility, injection drug users (IDU) can inject
pre-obtained illicit drugs under the supervision of medical
staff, and an addictions counsellor and nursing care are
available on site [8]. A major concern prior to the opening
of the SIF was that the facility would result in increased
migration of IDU and drug dealers to the city's Downtown
Eastside where the facility is located, and subsequently
prompt increases in criminal activity [8-11]. To examine
these concerns, the present study was therefore conducted
to examine patterns of criminal activity (drug trafficking
and other drug-related crime) in the city's Downtown
Eastside since the facility opened.
Methods
For the present analyses, we accessed Vancouver Police
Department statistics regarding charges for drug traffick-
ing (which is defined to include selling, administering,
giving, transferring, transporting, sending, or delivering
illicit drugs), assaults and robberies, and vehicle break-ins
and vehicle theft in the neighborhoods broadly defined as
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Monthly crude total number of charges for drug trafficking (Panel A), assaults and robbery (Panel B), and vehicle theft (Panel C)  in the year before versus the year after the SIF opened Figure 1
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the Downtown Eastside area (Downtown Eastside proper,
Chinatown, Gastown, Victory Square, and Strathcona).
These indicators were selected for several reasons. First,
although a reduction in public drug use and publicly dis-
carded syringes has been attributed to the opening of the
SIF [12], the potential influx of drug dealers to sell drugs
to the SIF's clientele has not been thoroughly investigated.
Second, rates of assaults and robberies and vehicle break-
ins and vehicle thefts were evaluated to assess the poten-
tial of an increase in drug-related crime, since these activ-
ities have been attributed to a concentrated illegal drug
scene in the neighborhood [12]. The categories of assaults
and robberies and vehicle break-ins and theft were com-
bined in the source data file and it was not possible to sep-
arate these indicators.
We compared the monthly average number of charges for
these activities in the Downtown Eastside between Octo-
ber 1, 2003 and September 30, 2004 (pre-SIF year) versus
the monthly average during the period October 1, 2004
and September 30, 2005 (post-SIF year). Since there were
a limited number of data points to compare trends
between years, data were plotted on line graphs, and aver-
age annual levels for each of the three indicators (drug
trafficking, assaults and robbery, and vehicle break-ins/
theft) were compared using paired t-tests.
Results
The crude monthly totals for the year prior versus the year
after the SIF opened are shown in Figure 1. As shown here,
there were no obvious differences between the two years
with respect to the various indicators of drug-related
crime.
Similarly, using a t-test, no increases were seen with
respect to: drug trafficking (124 [SD = 94] vs. 116 [SD 24];
mean difference = 7.9, t-stat = 0.26, df = 11, p = 0.803) and
assaults/robbery (174 [SD = 25] vs. 180 [SD = 21]; mean
difference = -6.2, t-stat = -0.59, df = 11, p  = 0.565),
although significant declines in vehicle break-ins/theft
were observed (302 [SD = 57] vs. 227 [SD = 48]; mean dif-
ference = 75.7, t-stat = 4.22, df = 11, p = 0.001).
Discussion
In the present study, when we compared annual periods
before and after the opening of the Vancouver SIF, we
found that rates of arrest for drug trafficking, assaults, and
robbery were similar after the facility's opening, although
rates of vehicle break-ins/theft declined significantly.
These results are consistent with a recent study of the
impact of Australia's first SIF which concluded that the
Sydney facility was not associated with an increase in the
proportion of drug use or supply offences [13].
The present study has several limitations. Most impor-
tantly, some crime statistics may be confounded by discre-
tionary policing practices and levels of police deployment.
Because of these issues, we did not investigate reports of
drug possession, since the Vancouver Police Department
has a discretionary approach towards drug possession.
Specifically, in many instances police have directed or
escorted IDU to the SIF, whereas during other periods an
increased number of possession charges have been laid
against IDU injecting in public reportedly as a police strat-
egy to maximize use of the SIF and to reduce public disor-
der. Nevertheless, with respect to public drug use, an
earlier study reported reductions in public drug use as
measured by four independent measures [12]. In contrast
to their approach to drug possession, the local police have
a zero tolerance approach towards drug trafficking. Never-
theless, this measure suffers from uneven levels of police
deployment between periods, which was evident in the
drug trafficking data. Specifically, there are periodic
increases in police activity that cannot be accounted for,
and there was a spike in the drug trafficking data in the
pre-SIF year coinciding with a well described police crack-
down [14], and hence the small decline in drug trafficking
charges in the post-SIF year is due to this effect. Finally,
although the statistically significant decrease in vehicle
break-ins/thefts in the post-SIF period does not appear to
be due to the police crackdown in the pre-SIF period, due
to the above concerns, we caution against inferring that
this reduction was due to the SIF. Instead, we believe our
overall findings suggest that the SIF was not associated
with a marked increase in drug-related criminal activity.
In summary, the present study suggests that the opening
of North America's first medically supervised safer inject-
ing facility was not associated with a marked increase in
drug trafficking or acquisitive crimes in the year after the
facility opened. These findings suggest that the benefits of
the SIF on public drug use and HIV risk behavior have not
been offset by an increase in criminal activity in the neigh-
borhood [12,15]. These findings should make a valuable
contribution to the ongoing debates regarding the value
of SIF, and for the cities in Canada and elsewhere that are
considering initiating SIF trials [8-10,16-19].
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